Testing Drug Phototoxicity in Mice*  by Ison, Arnold & Blank, Harvey
Cutaneous reactions to sunlight in patients
taking drugs have increased as new compounds
have been introduced into medicine (1—5). The
feasibility of studying these reactions in lab-
oratory animals was suggested by three con-
siderations: the major groups of drugs con-
cerned are phototoxic not photoallergic, skin
reactions can be elicited by "long wave" ultra-
violet, and stable convenient sources of such
ultraviolet radiation arc now available.
If photocutancous reactions were allergic
responses to drugs, laboratory animals, hkc
patients, would have to be sensitized before
they would react. From earlier studies in our
laboratories, some of which have been pub-
lished (6), we felt that most photosensitizing
drugs would cause reactions regularly on ini-
tial exposure if adequate amounts of com-
pound were given. Clinical observations of the
variable incidence of photosensitive reactions
probably could be explained by different tissue
levels of drugs and variable amounts of acti-
vating light. The view that most of the drugs
concerned were phototoxic was further
strengthened by the demonstration with many
of them of a phototoxic effect in yeast (7) and
studies with psoralens in both guinea pigs and
man (8—9). We therefore anticipated that if
we gave animals a single dose of drug that
was large enough they would practically all re-
act to light. One prominent exception is tn-
bromsalicylanilide, an antibacterial prepara-
tion used in soaps and lotions which probably
is a photoallergen and requires preliminary
sensitization exposure (10—11).
Much of the earlier literature describing at-
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tempts to study photosensitivity reactions in
man is conflicting as to the wave lengths of
radiation required (3). This probably occurred
for two reasons. Many of the light sources
that were used did not have an adequate
output of "long wave" ultraviolet, i.e. greater
than 320 nm (nanometers), and as a result
when a filter that excluded wave lengths below
320 nm was used there was negligible radiation
to the skin (12). Another difficulty was that of
distinguishing normal erythema from abnor-
mal reactions when sunburn wave lengths
were used, especially because the large doses
often recommended could cause even papular
lesions in normal subjects (13). The likelihood
that most of the drugs could be activated by
wave lengths of light greater than 320 nm,
which would not by themselves cause ery-
thcma, was indicated by earlier studies in this
laboratory and elsewhere (6, 14). This is now
getting general acceptance (5, 15—17). We had
found that long wave radiation which goes
through window glass would cause reactions in
human skin only where the drug had been
introduced and caused no reaction in normal
skin (6). Clear and unequivocal end-points
were easier to determine than when ultraviolet
of shorter, burning wave lengths was used.
The commercial introduction of inexpensive
fluorescent ultraviolet lamps with a substantial
output of radiation above 320 nm made sources
available which were convenient, stable, and
which produce little heat and no reaction in
normal mouse skin even after 48 hours' con-
tinuous radiation.
The purpose of this study was to combine
these observations into a dependable labora-
tory procedure which would provide quantita-
tive data by which the phototoxic potential of
compounds could be determined. To perfect
the procedure, drugs which are generally recog-
nized as causing adverse photocutaneous re-
actions were used and exposures to natural
sunlight, sunlight through window glass and
to laboratory irradiation were compared, using
the skin of hairless mice as the indicator sys-
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continuous radiation with the fluorescent source,
and at eight and 24 hours following the two
hours of natural sunlight exposure. A compound
was considered phototoxic if drug injected irra-
diated animals had more erythema or dermatitis
than the controls at each evaluation period (Fig.
2).
RESULTS
Fm. 1: Phototoxie reaction in hairless mice. A.
Drug injected and irradiated. B. Vehicle injected
and irradiated. C. Drug injected and not irradiated.
Only A shows characteristic erythematous and
edematous reaction.
METHOU5
Pure powder of compounds to be tested was
suspended or dissolved in an aqueous viscous
solution1 and injected intraperitoneally into al-
bino hairless mice (hrs/J). All mice were previously
untreated and unirradiated. Drugs were given in
one dose in amounts of 660, 66, 33, and 6.6 mgm
per kilogram. With some compounds intermediate
amounts and multiple injections were given. At
least two animals were injected at each dose level
and the experiments were repeated. Irradiation
was started immediately after injection.
The fluorescent ultraviolet source consisted of
two General Electric F-40 BL lamps (300—400 am)
in a standard 4 ft white fixture. Animals were ex-
posed to this source in individual glass beakers
covered by window glass at a distance of 10 in.
for 48 hr. The intensity of radiation the animals
received was approximately 320 microwatts/cm2
as measured with a YSI radiometer. In natural
sunlight experiments, animals were housed in
individual wire cages with a 1 cm mesh and ex-
posed to unfiltered sunlight or to sunlight filtered
through window glass. The animals were irradiated
for two hours between 11:00 am and 1:00 pm on
cloudless days. The intensity of ultraviolet irra-
diation was approximately 10 times that with BL
lamps. Experiments were performed from mid-
winter to spring. Window glass used in these ex-
periments when examined in a speetrophotometer
had no transmittance below 315 nm and very little
below 320 nm.
Animals injected with the vehicle alone and
irradiated, as well as animals injected with drug
but kept in total darkness, served as controls
(Fig. 1). Experimental animals were compared
anonymously to controls after 24 and 48 hours of
With all three sources of light, phototoxieity
was demonstrated with: 8-methoxypsoralen,
ehlorpromazine, proehlorperazine, demethyl-
ehlortetracyeline, tetracycline (18), and the
experimental antimalarial SN 10275 (6, 5-
dichloro 2- phenyl - a - 2 piperidyl - 4- quinoline
methanol) (19). Chlorothiazide phototoxicity
was seen only with window glass filtered
natural sunlight (Table I). No phototoxieity
was elicited with tolbutamide or trihrom-
salicylanilide (TBS) even when multiple sub-
lethal doses were given.
Table I shows representative experiments
and illustrates that phototoxicity is dose
related. Control animals irradiated with un-
filtered natural sunlight developed distinct
erythcma but controls exposed through a win-
dow glass filter either to natural sunlight or to
black light had either no erythema or neg-
ligible redness.
The dose at which phototoxicity was seen
in 50 per cent of animals tested (PTD55) was
calculated (20). The PTDO levels were repro-
ducible in individual black light experiments
but when natural sunlight studies were done
several months apart the dose required varied.
The PTDO levels calculated from all experi-
ments arc shown in Table II. It took less
Fm. 2. Severe phototoxic reaction. Both mice
were irradiated with long wave ultraviolet light.
A. Drug injected. B. Vehicle injected control.
'Sodium carboxymethylcellulose, 7.5 gm; Tween
80, 0.4 ml; sodium chloride, 5.7; benzyl alcohol, 9
ml, and distilled water to make 1 L which results
in a final pH of 7.4.
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demethylehiortetracycline than tetracycline to
induce a photosensitive reaction and less
chlorpromazine than prochiorperazine with
artificial light. The level of response to sun-
light sources with some compounds tested did
not always exactly parallel the black light ex-
periments but with the exception of chioro-
thiazide all animals showing a reaction with
one irradiation source also showed it with
the others.
TABLE I
nose Back light Sunlight Unfiltered(mgm/kg) and glass and glass sunlight
8-methoxypsoralen treated
660
66
33
6.6
0
lethal
4+
4+
0
0
lethal lethal
4+ 4+
4+ 4+
0 2+
0 2+
Chlorothiazide treated
660
66
33
6.6
0
0
0
0
0
0
1+
1+
0
0
0
2+
2+
2+
2+
2+
D150U5510N
Phototoxicity was produced with most com-
pounds tested and these results correlate with
recently published guinea pig studies (15, 16).
In contrast with previous workers (16) we had
no difficulty demonstrating phototoxicity
with tetracycline using artificial sources. The
greater phototoxic potential of demethylchlor-
tetracycline over tetracycline correlates well
with human experience (6, 17, 18). No photo-
toxicity was elicited in our system with tn-
bromosalicylanilide presumably because it is a
photoallergen. The reason for the negative
photocutancous reaction with tolbutamide is
not known.
In all instances phototoxicity was demon-
strated with light filtered through window
glass and illustrates that only long wave ultra-
violet is necessary to obtain positive tests.
The chlorothiazide results show that positive
phototoxicity tests may be masked by normal
ultraviolet crythcma. With most compounds
phototoxicity was produced with the black
light as well as with natural sunlight. Ex-
periments with chlorothiazide indicate that
when no phototoxicity is seen with an arti-
ficial light source, natural sunlight studies
should he done before a compound is con-
sidered negative.
Phototoxicity was dose related and quan-
titative data was obtained with all three
methods of irradiation used, but results with
natural sunlight were variable. This varia-
TABLE II
Dose at which 50% of animals developed a
* Animals injected daily for 4 days.
Representative results of irradiation of hairless mice
0 = no erythema in animals; 1—3+ = slight to
marked erythemn; 4+ = erythema plus edema or
dermatitis.
phototoxic reaction (PT135) (mgm//cg)
nrug
Black light and glass Unfiltered sunlight Sunlight and glass
PTD55
No. of
animals
tested
PTD,5
No. of
animals
tested
PTD55
No. of
animals
tested
8-Methoxypsoralen
Chlorpromazine
Prochlorperazine
Demethylchlortetra-
cycline
Tetracycline
SN10257
Chlorothiazidc
Tolbutamide
Tribromsalicylanilide
20
20
46
50
155
13
No phototoxicity
No phototoxicity
No phototoxicity
10
10
16
11
12
20
14*
12
4
20
30
20
7
13
20
Same as controls
Same as controls
Same as controls
6
15
12
9
8
8
6
2*
2*
24
17
20
27
42
13
55
No phototoxicity
No phototoxicity
12
12
10
16
24
13
14
4*
2*
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bility is most likely the result of conducting
experiments over several months while ultra-
violet intensity was changing.
SUMMARY
Quantitative measurements of the photo-
toxicity of methoxypsoralen, phenothiazines,
tetracyclines, a quinoline methanol, and chloro-
thiazide can be made in hairless mice. Results
of irradiation with a fluorescent long wave
ultraviolet source in the laboratory are fairly
comparable to natural sunlight exposures.
Ranking drugs by their phototoxic doses in
mice parallels human experience with drug
induced photosensitivity eruptions.
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